Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts NAUT Hot Sheet
Join SI Premium – FREE
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Independent Bank receives regulatory approval for HCB Financial acquisition
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
